Borosil Scientific Ltd

Business overview

• Dec 2023 demerger formed Borosil Scientific Limited from Borosil Ltd.
• Core segments: Laboratory Glassware & Consumables, Lab Equipment, Process Systems, Pharma Primary Packaging.
• Part of the Borosil Group; focus on laboratory solutions and Make in India.
• Strategic emphasis on LabQuest and Process Sciences; expanding exports.

Operational highlights

• Q1FY27 consolidated net sales ₹106.8 cr, up 11.2% YoY.
• PAT ₹4.4 cr.
• Pharma Packaging revenue +31.6% YoY; Lab Equipment +31.4%; Process System +8.6%.
• Lab Consumables revenue flat (-0.1%) due to Ind AS 115.
• Consolidated category totals: Lab Consumables ₹66.7 cr; Glassware ₹38.4 cr; Others ₹1.7 cr.
• Ind AS 115 impact noted; ex-IFRS Lab Consumables growth 7.4%.

Financial performance

• Consolidated Net Sales ₹106.8 cr; YoY 11.2%.
• EBITDA ₹8.7 cr; margin 8.2%.
• EBIT ₹3.8 cr; PBT ₹6.0 cr; PAT ₹4.4 cr.
• Net debt (period end) ₹(136.8) cr.

Capital structure & liquidity

• Net debt (period end) ₹(136.8) cr.

Strategic priorities & outlook

• Medium-term revenue CAGR 12-14%.
• Expand LabQuest and Process Sciences; broaden client base.
• Export growth across product categories.
• 450 kW solar rooftop commissioned Feb 2025.
• 10 KLD STP for wastewater recycling commissioned Oct 2024.
• Make in India manufacturing base; leverage China Plus One opportunities.

Risks & mitigation

• Ind AS 115 impact on Lab Consumables revenue.

Governance & leadership

• Dec 2023 demerger of scientific business formed Borosil Scientific Limited.
• Board includes Pradeep Kheruka, Vinayak Patankar, Chandra Mishra, Shreevar Kheruka, Kewal Handa, Anupa Sahney.

Meeting Details

• Board meeting scheduled for Monday, August 3, 2026; time and venue not disclosed.

Key Agenda Items

• Consider and approve unaudited standalone and consolidated financial results for quarter ended June 30, 2026.

Other Notes

• Trading window closed from July 1, 2026; remains closed till 48 hours after results declaration.

Cessation of Senior Managerial Personnel

• Mr. Sharad Tiwari ceases to be Senior Managerial Personnel with effect from July 14, 2026.
• Reason: internal reporting structure change; remains associated with the Company.

Dematerialisation status

• All securities are in dematerialised form.
• No Demat/Remat requests were received during the reporting period.

Clarification on increase in scrip volume

• Company states no material information was withheld; price/volume rise is market-driven.
• Signed by Ramavtar Sharma, Company Secretary & Compliance Officer.